National Health Investors, Inc. (NYSE:NHI) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a note issued to investors on Friday. The firm currently has a $89.00 price target on the real estate investment trust’s stock. Zacks Investment Research‘s price objective points to a potential upside of 11.26% from the stock’s current price.

According to Zacks, “National Health Investors, Inc. is a real estate investment trust which invests in income producing health care properties primarily in the long-term care industry. The company provides current income for distribution to stockholders through investments in health care related facilities, including long-term care facilities, acute care hospitals, medical office buildings, retirement centers and assisted living facilities. “

A number of other equities research analysts have also recently issued reports on the company. Bank of America Corporation cut National Health Investors from a “neutral” rating to an “underperform” rating and set a $76.00 price objective on the stock. in a research note on Monday, May 22nd. Mizuho restated a “neutral” rating on shares of National Health Investors in a research note on Wednesday, June 28th. Stifel Nicolaus increased their price target on National Health Investors from $80.00 to $82.00 and gave the company a “buy” rating in a research note on Wednesday, June 21st. BidaskClub cut National Health Investors from a “buy” rating to a “hold” rating in a research note on Saturday, July 8th. Finally, ValuEngine cut National Health Investors from a “buy” rating to a “hold” rating in a research note on Tuesday, June 13th. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating and two have assigned a buy rating to the company. The company has a consensus rating of “Hold” and a consensus target price of $80.50.

Shares of National Health Investors (NYSE:NHI) traded up 0.13% during midday trading on Friday, hitting $79.99. 386,518 shares of the stock traded hands. The firm’s 50 day moving average price is $78.56 and its 200 day moving average price is $75.95. National Health Investors has a 12-month low of $66.31 and a 12-month high of $81.29. The company has a market capitalization of $3.28 billion, a PE ratio of 20.54 and a beta of 0.56.

National Health Investors (NYSE:NHI) last announced its quarterly earnings data on Wednesday, August 9th. The real estate investment trust reported $0.93 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.29 by ($0.36). National Health Investors had a return on equity of 12.56% and a net margin of 59.24%. The company had revenue of $69.84 million for the quarter, compared to the consensus estimate of $67.68 million. During the same quarter in the prior year, the company earned $1.22 EPS. The company’s revenue for the quarter was up 14.1% on a year-over-year basis. Analysts expect that National Health Investors will post $3.85 EPS for the current year.

COPYRIGHT VIOLATION NOTICE: This story was posted by American Banking News and is the property of of American Banking News. If you are reading this story on another website, it was illegally copied and republished in violation of US and international copyright and trademark laws. The original version of this story can be accessed at https://www.americanbankingnews.com/2017/09/16/national-health-investors-inc-nhi-stock-rating-upgraded-by-zacks-investment-research.html.

In related news, insider Kevin Carlton Pascoe sold 2,000 shares of the stock in a transaction on Thursday, August 24th. The stock was sold at an average price of $79.80, for a total value of $159,600.00. Following the sale, the insider now owns 21,228 shares in the company, valued at approximately $1,693,994.40. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 5.19% of the stock is currently owned by corporate insiders.

A number of hedge funds have recently bought and sold shares of the business. US Bancorp DE increased its position in National Health Investors by 0.5% during the 2nd quarter. US Bancorp DE now owns 8,836 shares of the real estate investment trust’s stock worth $700,000 after buying an additional 44 shares during the period. Woodmont Investment Counsel LLC increased its position in National Health Investors by 1.3% during the 2nd quarter. Woodmont Investment Counsel LLC now owns 3,414 shares of the real estate investment trust’s stock worth $270,000 after buying an additional 45 shares during the period. Daiwa Securities Group Inc. increased its position in National Health Investors by 1.7% during the 1st quarter. Daiwa Securities Group Inc. now owns 3,200 shares of the real estate investment trust’s stock worth $232,000 after buying an additional 55 shares during the period. Teacher Retirement System of Texas increased its position in National Health Investors by 2.0% during the 2nd quarter. Teacher Retirement System of Texas now owns 3,192 shares of the real estate investment trust’s stock worth $253,000 after buying an additional 62 shares during the period. Finally, QS Investors LLC increased its position in National Health Investors by 0.8% during the 2nd quarter. QS Investors LLC now owns 7,934 shares of the real estate investment trust’s stock worth $628,000 after buying an additional 62 shares during the period. Hedge funds and other institutional investors own 70.58% of the company’s stock.

National Health Investors Company Profile

National Health Investors, Inc is a self-managed real estate investment trust (REIT) specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. The Company is engaged in the business of owning and financing healthcare properties.

Get a free copy of the Zacks research report on National Health Investors (NHI)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for National Health Investors Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors Inc. and related companies with MarketBeat.com's FREE daily email newsletter.